2016
DOI: 10.1016/j.fertnstert.2016.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Quantifying the intraindividual variation of antimüllerian hormone in the ovarian cycle

Abstract: Total variation in AMH was 20%, and the majority of this was biological. Changes in AMH resulted in reclassification in 29% of women and occurred most frequently in those with low and reduced AMH. In cycling women, the variability in AMH should be considered by clinicians, especially if a result is close to a clinical cutoff.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
22
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(27 citation statements)
references
References 51 publications
(77 reference statements)
5
22
0
Order By: Relevance
“…The large variance in the pre‐ and post‐salpingectomy AMH levels in women with a high pre‐operative AMH level is in line with studies reporting increased variability as AMH levels increase, with expected biological variation of 20–40 pmol/L for women with a baseline of >30 pmol/L …”
Section: Discussionsupporting
confidence: 82%
“…The large variance in the pre‐ and post‐salpingectomy AMH levels in women with a high pre‐operative AMH level is in line with studies reporting increased variability as AMH levels increase, with expected biological variation of 20–40 pmol/L for women with a baseline of >30 pmol/L …”
Section: Discussionsupporting
confidence: 82%
“…Limitations of this study include the cross‐sectional design, and the relatively small number of participants who were able to produce sufficient DBS samples. Serum AMH has been shown in some clinical studies to have significant intra‐woman variation across the menstrual cycle, regardless of ovulatory status (Kissell et al, ) and when samples are collected over several months, particularly during perimenopause (Hadlow et al, ). Respecting the practice of research in this part of Mexico, we did not collect blood spots in the rural communities where we carried out additional investigations.…”
Section: Discussionmentioning
confidence: 99%
“…However, more recently, the stability of AMH concentrations across and between menstrual cycles has been the subject of considerable debate. Some initial clinical studies suggest that AMH is stable across the menstrual cycle, whereas recent findings have suggested substantial fluctuations across the cycle . In addition, the reproducibility of AMH measurements may be influenced by the assay used: older assays are known to exhibit substantial analytical variability, and data obtained with these assays must therefore be interpreted with caution .…”
Section: Introductionmentioning
confidence: 99%
“…Some initial clinical studies suggest that AMH is stable across the menstrual cycle, [9][10][11] whereas recent findings have suggested substantial fluctuations across the cycle. [12][13][14] In addition, the reproducibility of AMH measurements may be influenced by the assay used: older assays are known to exhibit substantial analytical variability, and data obtained with these assays must therefore be interpreted with caution. 15 The clinical implications of such variations may also have been overstated, as previous studies used large step changes in gonadotropin doses at specific AMH thresholds, 4 and the size of these dose adjustments may have masked any effect of AMH variability on oocyte yield.…”
Section: Introductionmentioning
confidence: 99%